Identification of autoantibodies associated with myelin damage in multiple sclerosis

[1]  H. Lassmann,et al.  Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna , 1998, Journal of Neuroimmunology.

[2]  R. Hohlfeld,et al.  Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. , 1997, Brain : a journal of neurology.

[3]  E. Benveniste.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis , 1997, Journal of Molecular Medicine.

[4]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[5]  Charles A. Janeway,et al.  Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice , 1996, The Journal of experimental medicine.

[6]  G. Morris.  Epitope mapping protocols , 1996 .

[7]  J. Liu,et al.  Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. , 1996, Journal of immunology.

[8]  C. Brosnan,et al.  Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.

[9]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[10]  L. Steinman,et al.  Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Takizawa,et al.  Use of 1.4-nm immunogold particles for immunocytochemistry on ultra-thin cryosections. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  M. Ruberg,et al.  Characterization and Expression of the cDNA Coding for the Human Myelin/Oligodendrocyte Glycoprotein , 1994, Journal of neurochemistry.

[13]  O. Majdic,et al.  Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.

[14]  R. Ravid,et al.  The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology , 1994, Journal of Neuroimmunology.

[15]  R. Martenson.  Myelin: Biology and Chemistry , 1992 .

[16]  H. Lassmann,et al.  The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.

[17]  A. Compston,et al.  The pathogenesis of demyelinating disease: insights from cell biology , 1991, Trends in Neurosciences.

[18]  T. Olsson,et al.  T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. , 1991, Journal of immunology.

[19]  H. Lassmann,et al.  Differential Ultrastructural Localization of Myelin Basic Protein, Myelin/Oligodendroglial Glycoprotein, and 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in the CNS of Adult Rats , 1989, Journal of neurochemistry.

[20]  Immunogold localization and analysis of IgG during immune-mediated demyelination. , 1988 .

[21]  C. Raine,et al.  Immunogold localization and analysis of IgG during immune-mediated demyelination. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[22]  H. Lassmann,et al.  Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) , 1987, Journal of Neuroimmunology.

[23]  H. Lassmann,et al.  Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.

[24]  L. Epstein,et al.  Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis , 1983, Journal of the Neurological Sciences.

[25]  D. Willenborg,et al.  Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis , 1983, Journal of Neuroimmunology.

[26]  C. Brosnan,et al.  Analysis of humoral and cellular events and the role of lipid haptens during CNS demyelination. , 1983, Acta neuropathologica. Supplementum.

[27]  C. Raine,et al.  Demyelination in vitro Absorption studies demonstrate that galactocerebroside is a major target , 1981, Journal of the Neurological Sciences.

[28]  J. Prineas,et al.  The fine structure of chronically active multiple sclerosis plaques , 1978, Neurology.

[29]  H. Wiśniewski,et al.  Vesicular disruption of myelin in autoimmune demyelination , 1975, Journal of the Neurological Sciences.

[30]  C. Raine,et al.  Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. , 1974, Laboratory investigation; a journal of technical methods and pathology.

[31]  C. Raine,et al.  Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. , 1973, Journal of the neurological sciences.

[32]  C. Raine,et al.  EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: AN ULTRASTRUCTURAL STUDY OF EXPERIMENTAL DEMYELINATION IN VITRO , 1970, Journal of neuropathology and experimental neurology.

[33]  E. Alvord,et al.  The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. , 1968, Experimental neurology.

[34]  R. Katzman.,et al.  FINE STRUCTURE AND ELECTROLYTE ANALYSES OF CEREBRAL EDEMA INDUCED BY ALKYL TIN INTOXICATION , 1963, Journal of neuropathology and experimental neurology.